Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-22
2005-02-22
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S330000, C514S346000, C514S613000, C546S153000, C546S225000, C546S298000, C564S163000
Reexamination Certificate
active
06858626
ABSTRACT:
The present application describes novel cyclic hydroxamic acids of formula I:or pharmaceutically acceptable salt forms thereof, wherein ring B is a 5-7 membered cyclic system containing from 0-2 heteroatoms selected from O, N, NRa, and S(O)p, and 0-1 carbonyl groups and the other variables are defined in the present specification, which are useful as metalloprotease inhibitors.
REFERENCES:
patent: 4207091 (1980-06-01), Fischer
patent: 6211154 (2001-04-01), Scarborough et al.
patent: 2705034 (1977-08-01), None
patent: 0780306 (1997-06-01), None
patent: 0780386 (1997-06-01), None
patent: 0818442 (1998-01-01), None
patent: 9209282 (1992-06-01), None
patent: 9633172 (1996-10-01), None
patent: 9720824 (1997-06-01), None
patent: 9816506 (1998-04-01), None
patent: 9932451 (1999-07-01), None
patent: WO 9965867 (1999-12-01), None
Hanessian et al, “Synthesis of conformationally constrained potential inhibitors of mammalian metalloproteinases”, Bioorg. Med. Chem. Lett., vol. 7, No. 24, (1997), pp. 3119-3124.
Bade, Maria L., “Aminoacylhydroxamates. A case of slow proton transfer between electronegative atoms in solution”, J. Amer. Chem. Soc., vol. 93, No. 4, (1971) pp. 949-953.
Wahl, Robert C., “Biochemistry and Inhibition of Collagenase and Stromelysin”, Ann. Rep. Med. Chem., 25, 177-184, AP, San Diego, 1990.
Sharma, CA 112:98439, 1989.
Fushimi, CA 113:123796, 1989.
Decicco Carl P.
He Xiaohua
Xue Chu-Biao
Belfield Jing S.
Bristol-Myers Squibb Pharma Company
Seaman D. Margaret
Vance David H.
LandOfFree
Cyclic hydroxamic acid as metalloproteinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic hydroxamic acid as metalloproteinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic hydroxamic acid as metalloproteinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3485526